- Home
- OLB vs RDHL Comparison
OLB vs RDHL Comparison
Compare OLB & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLB
- RDHL
- Stock Information
- Founded
- OLB 1993
- RDHL 2009
- Country
- OLB United States
- RDHL Israel
- Employees
- OLB N/A
- RDHL N/A
- Industry
- OLB EDP Services
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- OLB Technology
- RDHL Health Care
- Exchange
- OLB Nasdaq
- RDHL Nasdaq
- Market Cap
- OLB 4.4M
- RDHL 3.9M
- IPO Year
- OLB N/A
- RDHL N/A
- Fundamental
- Price
- OLB $1.33
- RDHL $1.70
- Analyst Decision
- OLB
- RDHL
- Analyst Count
- OLB 0
- RDHL 0
- Target Price
- OLB N/A
- RDHL N/A
- AVG Volume (30 Days)
- OLB 92.0K
- RDHL 43.1K
- Earning Date
- OLB 11-14-2025
- RDHL 09-05-2025
- Dividend Yield
- OLB N/A
- RDHL N/A
- EPS Growth
- OLB N/A
- RDHL N/A
- EPS
- OLB N/A
- RDHL N/A
- Revenue
- OLB $10,410,379.00
- RDHL $9,550,000.00
- Revenue This Year
- OLB N/A
- RDHL $381.91
- Revenue Next Year
- OLB N/A
- RDHL N/A
- P/E Ratio
- OLB N/A
- RDHL N/A
- Revenue Growth
- OLB N/A
- RDHL 157.62
- 52 Week Low
- OLB $0.95
- RDHL $1.06
- 52 Week High
- OLB $3.27
- RDHL $11.70
- Technical
- Relative Strength Index (RSI)
- OLB 52.10
- RDHL 63.39
- Support Level
- OLB $1.21
- RDHL $1.47
- Resistance Level
- OLB $1.36
- RDHL $1.71
- Average True Range (ATR)
- OLB 0.11
- RDHL 0.09
- MACD
- OLB 0.03
- RDHL 0.05
- Stochastic Oscillator
- OLB 75.23
- RDHL 97.96
About OLB The OLB Group Inc.
The OLB Group Inc is a diversified fintech e-commerce merchant services provider and Bitcoin crypto mining enterprise. It focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. Along with its subsidiaries, the company offers a cloud-based business management platform that provides turnkey solutions for merchants to enable them to build and manage their retail businesses, whether online or at a brick-and-mortar location, payment processing solutions, payment gateway, virtual terminal with proprietary business management tools, and crowdfunding solutions. The company has two business segments; Fintech Services which generates key revenue, and the Bitcoin Mining business segment.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.